Pranayama for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Pranayama for Health & Longevity

Created on 09/01/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Slow breathing at around six breaths a minute produces a modest but consistent fall in resting blood pressure, slows the resting pulse, and shifts heart rhythm toward a calmer pattern. Mood gains weaken against a convincing dummy practice; sleep gains hold on questionnaires only. Harms sit almost entirely with the fast, forceful techniques. Cost is close to zero. (Full Review)

Protocol

Core slow-breathing protocol
5–6 breaths per minute, 10–20 minutes daily
Nasal in and out, seated with an upright spine. The pattern most trials in the meta-analyses employed.
Best time of day
Slow in the evening, forceful in the morning
Slow techniques suit pre-sleep use; forceful techniques disrupt sleep if practiced within 4 hours of bed.
Single session versus split sessions
One 15–20 minute block or two 10-minute blocks
Split dosing suits anxiety and blood pressure; a single evening block suits sleep.
Time to effect
Blood pressure
4–8 weeks
Measurable reduction typically appears with daily practice.
Heart rate and calmness
1–3 minutes
Acute change is immediate and fades within 15–60 minutes of stopping.
Sleep and mood
2–4 weeks
Self-report shifts; daily repetition is the mechanism of any lasting change.

Benefits

Contraindications
  • Epilepsy, prior unexplained seizure, or anti-seizure drugs (fast techniques and all breath retention)
  • Uncontrolled high blood pressure above 180/110 mmHg (forceful techniques, until controlled)
  • Heart attack or unstable chest pain within 90 days, or New York Heart Association Class IV heart failure
  • Stroke or transient ischemic attack within 90 days, or a known brain aneurysm
  • Advanced glaucoma or prior retinal detachment (forceful techniques and inverted practice)
  • Pregnancy (forceful abdominal techniques and breath retention, from the first trimester onward)
  • Untreated pneumothorax, thoracic or abdominal surgery within six weeks, or an uncontrolled hernia
  • Any breath-hold practice in or beside water, for everyone without exception
    •
Key Interactions
  • Blood-pressure-lowering drugs (amlodipine, lisinopril, losartan, hydrochlorothiazide): Caution and monitor
  • Beta blockers, drugs that slow the heart (metoprolol, bisoprolol, propranolol): Monitor
  • Over-the-counter decongestants (pseudoephedrine, phenylephrine) and high-dose caffeine: Caution
  • Over-the-counter anti-inflammatory painkillers (ibuprofen, naproxen): Monitor
  • Blood-pressure-lowering supplements (beetroot nitrate, magnesium, potassium, hibiscus, garlic extract, omega-3 fatty acids): Caution, additive
  • Sedating supplements (melatonin, valerian, high-dose magnesium glycinate, L-Theanine): Monitor
  • Other interventions (cold exposure, sauna, breath-hold training, altitude or pressure-chamber training): Caution through absolute contraindication
    •

Risk & Side Effects

  • High: Hyperventilation-provoked seizures in susceptible individuals; acute hypocapnic symptoms from fast-breathing techniques
  • Medium: Acute rise in heart rate and blood pressure during forceful techniques; fainting from combined over-breathing and breath-holding
  • Low: Serious injury reported in case reports; psychological distress during intense breathwork sessions
  • Speculative: Chronic hypocapnia from habitual over-breathing

Monitoring

Marker Target Why
Resting blood pressure Below 120/80 mmHg; changes of 5 mmHg or more are meaningful Primary measurable circulatory response
Resting heart rate 50–65 beats per minute Tracks the shift in vagal ("rest-and-digest") tone
Heart rate variability (RMSSD) No established target; a rise of 10% or more over a personal 30-day baseline Direct index of the mechanism pranayama targets
Resting respiratory rate 8–12 breaths per minute Shows whether slow breathing has carried over beyond practice sessions
Spirometry (FEV1, FVC, peak expiratory flow) FEV1 at 100% or more of predicted; FEV1/FVC ratio 0.75 or higher Detects change or decline in lung function
Breath-hold tolerance and end-tidal carbon dioxide Breath-hold 25 seconds or more; end-tidal carbon dioxide 35–45 mmHg Flags chronic over-breathing and low-carbon-dioxide risk
Fasting glucose and HbA1c Glucose 75–86 mg/dL; HbA1c 4.9–5.3% Detects the metabolic effect claimed for longer programs
hs-CRP Below 1.0 mg/L General inflammation marker frequently reported in yoga trials
Morning saliva cortisol 0.10–0.30 µg/dL at 30 minutes after waking Stress-axis marker used as an endpoint in pranayama trials
Overnight oximetry and apnea–hypopnea index Mean SpO2 94% or above; apnea–hypopnea index below 5 events per hour Establishes whether sleep-disordered breathing is present and responding

Cadence: Blood pressure and resting heart rate weekly for the first 8 weeks, then monthly; heart rate variability and resting breathing rate at 8 weeks and again at 6 months; breathing tests, overnight oxygen screening and metabolic markers at 6 and 12 months.

Qualitative Assessment

  • Ease and quietness of nasal breathing at rest, and whether mouth breathing returns under mild exertion
  • Time taken to fall asleep, and the number of night wakings
  • Morning energy on waking, tracked separately from total sleep duration
  • Speed of recovery from an acute stressor
  • Cognitive clarity and sustained attention during the two hours after practice
  • Whether the slow rhythm starts appearing spontaneously outside practice sessions
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.